Literature DB >> 11327596

Dimeric L-dopa derivatives as potential prodrugs.

A Di Stefano1, B Mosciatti, G M Cingolani, G Giorgioni, M Ricciutelli, I Cacciatore, P Sozio, F Claudi.   

Abstract

A series of dimeric derivatives (+)-1, and (+)-2, and (+)-3a-d of L-Dopa diacetyl esters was synthesized and evaluated as potential L-Dopa prodrugs with improved physicochemical properties. All the new compounds showed chemical stability in aqueous buffer solutions (pH 1.3 and 7.4). A relatively slow release of L-Dopa in human plasma was observed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11327596     DOI: 10.1016/s0960-894x(01)00140-8

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Oxalyl retro-peptide gelators. Synthesis, gelation properties and stereochemical effects.

Authors:  Janja Makarević; Milan Jokić; Leo Frkanec; Vesna Caplar; Nataša Sijaković Vujičić; Mladen Zinić
Journal:  Beilstein J Org Chem       Date:  2010-10-04       Impact factor: 2.883

2.  α-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studies.

Authors:  Sergey Shityakov; Jens Broscheit; Carola Förster
Journal:  Int J Nanomedicine       Date:  2012-06-27

3.  Novel L-Dopa and dopamine prodrugs containing a 2-phenyl-imidazopyridine moiety.

Authors:  Nunzio Denora; Valentino Laquintana; Angela Lopedota; Mariangela Serra; Laura Dazzi; Giovanni Biggio; Dhananjay Pal; Ashim K Mitra; Andrea Latrofa; Giuseppe Trapani; Gaetano Liso
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.580

Review 4.  Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease.

Authors:  Fatma Haddad; Maryam Sawalha; Yahya Khawaja; Anas Najjar; Rafik Karaman
Journal:  Molecules       Date:  2017-12-25       Impact factor: 4.411

Review 5.  Antiparkinson prodrugs.

Authors:  Antonio Di Stefano; Piera Sozio; Laura Serafina Cerasa
Journal:  Molecules       Date:  2008-01-16       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.